Selected research
Industry Research
Mosapride Industry Research Report 2026
Market perspective
The global Mosapride market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Mosapride market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Mosapride market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Mosapride market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Mosapride include DAIICHI SANKYO, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., SAWAI PHARMACEUTICAL CO., LTD., Sumitomo Dainippon Pharma, Konghong Pharmaceutical, HAOSON PHARMA and Lunan Pharmaceutical Group. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Mosapride market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Mosapride.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mosapride Market by Company
DAIICHI SANKYO
Dainippon Pharmaceutical Co., Ltd.
Nihon Generic
NIPPON CHEMIPHAR CO., LTD.
SAWAI PHARMACEUTICAL CO., LTD.
Sumitomo Dainippon Pharma
Konghong Pharmaceutical
HAOSON PHARMA
Lunan Pharmaceutical Group
Mosapride Segment by Type
Tablet
Capsule
Others
Mosapride Segment by Application
Gastritis
Dyspepsia
Others
Mosapride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mosapride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mosapride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mosapride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Mosapride companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Others
Applications
- Gastritis
- Dyspepsia
- Others
Companies covered
- DAIICHI SANKYO
- Dainippon Pharmaceutical Co., Ltd.
- Nihon Generic
- NIPPON CHEMIPHAR CO., LTD.
- SAWAI PHARMACEUTICAL CO., LTD.
- Sumitomo Dainippon Pharma
- Konghong Pharmaceutical
- HAOSON PHARMA
- Lunan Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Mosapride by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Tablet
- 2.2.3 Capsule
- 2.2.4 Others
- 2.3 Mosapride by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Gastritis
- 2.3.3 Dyspepsia
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Mosapride Breakdown Data by Type
- 3.1 Global Mosapride Historic Market Size by Type (2021-2026)
- 3.2 Global Mosapride Forecasted Market Size by Type (2027-2032)
4 Mosapride Breakdown Data by Application
- 4.1 Global Mosapride Historic Market Size by Application (2021-2026)
- 4.2 Global Mosapride Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Mosapride Market Perspective (2021-2032)
- 5.2 Global Mosapride Growth Trends by Region
- 5.2.1 Global Mosapride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Mosapride Historic Market Size by Region (2021-2026)
- 5.2.3 Mosapride Forecasted Market Size by Region (2027-2032)
- 5.3 Mosapride Market Dynamics
- 5.3.1 Mosapride Industry Trends
- 5.3.2 Mosapride Market Drivers
- 5.3.3 Mosapride Market Challenges
- 5.3.4 Mosapride Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Mosapride Players by Revenue
- 6.1.1 Global Top Mosapride Players by Revenue (2021-2026)
- 6.1.2 Global Mosapride Revenue Market Share by Players (2021-2026)
- 6.2 Global Mosapride Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Mosapride Head Office and Area Served
- 6.4 Global Mosapride Players, Product Type & Application
- 6.5 Global Mosapride Manufacturers Established Date
- 6.6 Global Mosapride Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Mosapride Market Size (2021-2032)
- 7.2 North America Mosapride Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Mosapride Market Size by Country (2021-2026)
- 7.4 North America Mosapride Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Mosapride Market Size (2021-2032)
- 8.2 Europe Mosapride Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Mosapride Market Size by Country (2021-2026)
- 8.4 Europe Mosapride Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Mosapride Market Size (2021-2032)
- 9.2 Asia-Pacific Mosapride Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Mosapride Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Mosapride Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Mosapride Market Size (2021-2032)
- 10.2 South America Mosapride Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Mosapride Market Size by Country (2021-2026)
- 10.4 South America Mosapride Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Mosapride Market Size (2021-2032)
- 11.2 Middle East & Africa Mosapride Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Mosapride Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Mosapride Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 DAIICHI SANKYO
- 12.1.1 DAIICHI SANKYO Company Information
- 12.1.2 DAIICHI SANKYO Business Overview
- 12.1.3 DAIICHI SANKYO Revenue in Mosapride Business (2021-2026)
- 12.1.4 DAIICHI SANKYO Mosapride Product Portfolio
- 12.1.5 DAIICHI SANKYO Recent Developments
- 12.2 Dainippon Pharmaceutical Co., Ltd.
- 12.2.1 Dainippon Pharmaceutical Co., Ltd. Company Information
- 12.2.2 Dainippon Pharmaceutical Co., Ltd. Business Overview
- 12.2.3 Dainippon Pharmaceutical Co., Ltd. Revenue in Mosapride Business (2021-2026)
- 12.2.4 Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio
- 12.2.5 Dainippon Pharmaceutical Co., Ltd. Recent Developments
- 12.3 Nihon Generic
- 12.3.1 Nihon Generic Company Information
- 12.3.2 Nihon Generic Business Overview
- 12.3.3 Nihon Generic Revenue in Mosapride Business (2021-2026)
- 12.3.4 Nihon Generic Mosapride Product Portfolio
- 12.3.5 Nihon Generic Recent Developments
- 12.4 NIPPON CHEMIPHAR CO., LTD.
- 12.4.1 NIPPON CHEMIPHAR CO., LTD. Company Information
- 12.4.2 NIPPON CHEMIPHAR CO., LTD. Business Overview
- 12.4.3 NIPPON CHEMIPHAR CO., LTD. Revenue in Mosapride Business (2021-2026)
- 12.4.4 NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio
- 12.4.5 NIPPON CHEMIPHAR CO., LTD. Recent Developments
- 12.5 SAWAI PHARMACEUTICAL CO., LTD.
- 12.5.1 SAWAI PHARMACEUTICAL CO., LTD. Company Information
- 12.5.2 SAWAI PHARMACEUTICAL CO., LTD. Business Overview
- 12.5.3 SAWAI PHARMACEUTICAL CO., LTD. Revenue in Mosapride Business (2021-2026)
- 12.5.4 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio
- 12.5.5 SAWAI PHARMACEUTICAL CO., LTD. Recent Developments
- 12.6 Sumitomo Dainippon Pharma
- 12.6.1 Sumitomo Dainippon Pharma Company Information
- 12.6.2 Sumitomo Dainippon Pharma Business Overview
- 12.6.3 Sumitomo Dainippon Pharma Revenue in Mosapride Business (2021-2026)
- 12.6.4 Sumitomo Dainippon Pharma Mosapride Product Portfolio
- 12.6.5 Sumitomo Dainippon Pharma Recent Developments
- 12.7 Konghong Pharmaceutical
- 12.7.1 Konghong Pharmaceutical Company Information
- 12.7.2 Konghong Pharmaceutical Business Overview
- 12.7.3 Konghong Pharmaceutical Revenue in Mosapride Business (2021-2026)
- 12.7.4 Konghong Pharmaceutical Mosapride Product Portfolio
- 12.7.5 Konghong Pharmaceutical Recent Developments
- 12.8 HAOSON PHARMA
- 12.8.1 HAOSON PHARMA Company Information
- 12.8.2 HAOSON PHARMA Business Overview
- 12.8.3 HAOSON PHARMA Revenue in Mosapride Business (2021-2026)
- 12.8.4 HAOSON PHARMA Mosapride Product Portfolio
- 12.8.5 HAOSON PHARMA Recent Developments
- 12.9 Lunan Pharmaceutical Group
- 12.9.1 Lunan Pharmaceutical Group Company Information
- 12.9.2 Lunan Pharmaceutical Group Business Overview
- 12.9.3 Lunan Pharmaceutical Group Revenue in Mosapride Business (2021-2026)
- 12.9.4 Lunan Pharmaceutical Group Mosapride Product Portfolio
- 12.9.5 Lunan Pharmaceutical Group Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst